ES3036888T3 - Eye drops for treatment of irritation or damage due to sjögren's syndrome - Google Patents
Eye drops for treatment of irritation or damage due to sjögren's syndromeInfo
- Publication number
- ES3036888T3 ES3036888T3 ES18711415T ES18711415T ES3036888T3 ES 3036888 T3 ES3036888 T3 ES 3036888T3 ES 18711415 T ES18711415 T ES 18711415T ES 18711415 T ES18711415 T ES 18711415T ES 3036888 T3 ES3036888 T3 ES 3036888T3
- Authority
- ES
- Spain
- Prior art keywords
- ophthalmic preparation
- use according
- treatment
- irritation
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762467139P | 2017-03-05 | 2017-03-05 | |
| PCT/IL2018/050184 WO2018163151A1 (en) | 2017-03-05 | 2018-02-19 | Eye drops for treatment of irritation not due to infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3036888T3 true ES3036888T3 (en) | 2025-09-25 |
Family
ID=61656085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18711415T Active ES3036888T3 (en) | 2017-03-05 | 2018-02-19 | Eye drops for treatment of irritation or damage due to sjögren's syndrome |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11033513B2 (enExample) |
| EP (2) | EP4385565A3 (enExample) |
| JP (1) | JP7258778B2 (enExample) |
| KR (1) | KR102652879B1 (enExample) |
| CN (1) | CN110891555B (enExample) |
| AU (1) | AU2018230262B2 (enExample) |
| BR (1) | BR112019018367A2 (enExample) |
| CA (1) | CA3055523C (enExample) |
| ES (1) | ES3036888T3 (enExample) |
| IL (1) | IL269133B2 (enExample) |
| MX (1) | MX388961B (enExample) |
| PL (1) | PL3592339T3 (enExample) |
| RU (1) | RU2019130955A (enExample) |
| WO (1) | WO2018163151A1 (enExample) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL80298A (en) | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| US5895645A (en) * | 1995-01-31 | 1999-04-20 | Bausch & Lomb Incorporated | Opthalmic solution for artificial tears |
| JP3093661B2 (ja) * | 1995-10-12 | 2000-10-03 | 大塚製薬株式会社 | 眼疾患治療剤 |
| AR004214A1 (es) * | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| IL120005A (en) * | 1997-01-14 | 2000-08-31 | Ramot University Authority Of | Pharmaceutical compositions for the treatment of the eye |
| US5800807A (en) * | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| IL168603A (en) * | 2005-05-16 | 2011-05-31 | Resdevco Res And Dev Co | Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells |
| DE102005055275A1 (de) | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| IL212725A (en) * | 2011-05-05 | 2016-06-30 | Resdevco Res And Dev Co | Glycerol Preparation for Non-surgical Conjunctivochalysis |
| ES2751248T3 (es) * | 2011-11-24 | 2020-03-30 | Toyo Sugar Refining Co Ltd | Agente protector queratoconjuntival o agente inhibidor de trastornos queratoconjuntivales |
| US9278132B2 (en) | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
-
2018
- 2018-02-19 PL PL18711415.2T patent/PL3592339T3/pl unknown
- 2018-02-19 AU AU2018230262A patent/AU2018230262B2/en active Active
- 2018-02-19 IL IL269133A patent/IL269133B2/en unknown
- 2018-02-19 EP EP24173992.9A patent/EP4385565A3/en active Pending
- 2018-02-19 EP EP18711415.2A patent/EP3592339B1/en active Active
- 2018-02-19 JP JP2019568840A patent/JP7258778B2/ja active Active
- 2018-02-19 ES ES18711415T patent/ES3036888T3/es active Active
- 2018-02-19 CA CA3055523A patent/CA3055523C/en active Active
- 2018-02-19 BR BR112019018367A patent/BR112019018367A2/pt not_active Application Discontinuation
- 2018-02-19 MX MX2019010471A patent/MX388961B/es unknown
- 2018-02-19 WO PCT/IL2018/050184 patent/WO2018163151A1/en not_active Ceased
- 2018-02-19 CN CN201880029944.8A patent/CN110891555B/zh active Active
- 2018-02-19 KR KR1020197029124A patent/KR102652879B1/ko active Active
- 2018-02-19 RU RU2019130955A patent/RU2019130955A/ru unknown
-
2019
- 2019-09-04 US US16/560,084 patent/US11033513B2/en active Active
-
2021
- 2021-03-03 US US17/191,191 patent/US11426361B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3592339C0 (en) | 2025-04-30 |
| WO2018163151A1 (en) | 2018-09-13 |
| AU2018230262A1 (en) | 2019-09-26 |
| PL3592339T3 (pl) | 2025-09-01 |
| IL269133A (en) | 2019-11-28 |
| US11426361B2 (en) | 2022-08-30 |
| EP4385565A3 (en) | 2024-08-21 |
| KR102652879B1 (ko) | 2024-03-29 |
| JP2020509092A (ja) | 2020-03-26 |
| RU2019130955A3 (enExample) | 2021-06-24 |
| RU2019130955A (ru) | 2021-04-07 |
| MX388961B (es) | 2025-03-20 |
| US20190388361A1 (en) | 2019-12-26 |
| EP4385565A2 (en) | 2024-06-19 |
| IL269133B2 (en) | 2024-09-01 |
| CA3055523A1 (en) | 2018-09-13 |
| EP3592339B1 (en) | 2025-04-30 |
| KR20190129065A (ko) | 2019-11-19 |
| IL269133B1 (en) | 2024-05-01 |
| EP3592339A1 (en) | 2020-01-15 |
| AU2018230262B2 (en) | 2024-01-18 |
| CN110891555B (zh) | 2023-12-26 |
| US11033513B2 (en) | 2021-06-15 |
| US20210186892A1 (en) | 2021-06-24 |
| JP7258778B2 (ja) | 2023-04-17 |
| MX2019010471A (es) | 2020-02-12 |
| CA3055523C (en) | 2024-10-01 |
| BR112019018367A2 (pt) | 2020-04-07 |
| CN110891555A (zh) | 2020-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2486793T3 (es) | Sistema polimérico de administración para una solución a base de prostaglandina no viscosa sin conservantes | |
| ES2550500T3 (es) | Uso de prostaglandinas F2alfa y análogos para la curación de lesiones de la córnea y la conjuntiva | |
| US11376275B2 (en) | Ophthalmic compositions with improved dessication protection and retention | |
| JP7614069B2 (ja) | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 | |
| JP2025023354A (ja) | 異物感改善用眼科組成物 | |
| ES2860098T3 (es) | Composición para la aplicación nasal | |
| US7820639B2 (en) | Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same | |
| ES3036888T3 (en) | Eye drops for treatment of irritation or damage due to sjögren's syndrome | |
| ES2760523T3 (es) | Composición oftálmica remanente, especialmente para el tratamiento de la sequedad ocular | |
| ES2960944T3 (es) | Composición y uso de una solución oftálmica a base de ácido hialurónico y arabinogalactano | |
| PL243275B1 (pl) | Kompozycja farmaceutyczna do regeneracji i nawilżania powierzchni oka | |
| TW201914590A (zh) | 抗壞血酸用於製備保護角膜內皮細胞的眼用組成物的用途 | |
| JP2019514887A (ja) | グリコーゲンとヒアルロン酸またはその塩との相乗的組み合わせを含む眼科用組成物 | |
| US20250302868A1 (en) | Hypochlorous acid-based dry eye formulations | |
| CN118103055A (zh) | 组氨素组合和治疗或抑制细胞损失的方法 | |
| WO2021156856A1 (en) | Topical opthalmological composition containing hyaluronate and taurine having non-newtonian rheological properties | |
| TW202320835A (zh) | 用於治療或抑制細胞損失之組氨素組合及方法 | |
| HK1178446B (en) | Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives | |
| ITRM20120361A1 (it) | Soluzioni oftalmiche per uso topico contenenti acido ialuronico crosslinkato |